Dr. Lipska is an endocrinologist at the Yale School of Medicine and a Clinical Investigator at the Yale-New Haven Hospital Center for Outcomes Research and Evaluation (CORE). Her research program seeks to better understand the balance of benefits and harms of glucose-lowering therapy in older adults with type 2 diabetes. Her current research projects are primarily focused on severe hypoglycemia. She is investigating trends in admissions for hypoglycemia among the elderly Medicare population; race, sex, and age disparities in these admissions; using qualitative research methods to explore reasons for hypoglycemia admissions; examining key risk factors for hypoglycemia; and developing prediction models for hypoglycemia. Based on these data, she seeks to develop and implement decision support tools to help clinicians and patients make better decisions about their care. Her overall goals are to generate data that patients and clinicians need—data which currently do not exist—so that they can make better, smarter treatment decisions.
In addition, Dr. Lipska works at CORE on the development of ambulatory care quality measures for the Centers for Medicare & Medicaid Services (CMS). She is currently leading the development of an outcome measure of care quality among people with diabetes mellitus.
YCCI Scholar 2013
Project: 11/01/13 - 10/31/15
Treatment-Related Determinants of SevereHypoglycemia in Type 2 Diabetes
|National Public Radio, The People's Pharmacy, "How is diabetes diagnosed and treated"||Presenter/Speaker||2019|
|U.S. House Committee on Energy & Commerce Hearing on “Priced out of a life-saving drug: The human impact of rising insulin prices"||Hearing on “Priced out of a life-saving drug: The human impact of rising insulin prices."||2019|
|National Public Radio, "Insulin Has Become Unaffordable. Patients Are Dying In Their Efforts To Ration Doses"||Insulin Has Become Unaffordable. Patients Are Dying In Their Efforts To Ration Doses||2019|
|Endocrine Section Gender Equity Committee||Committee Member||2018 - Present|
|Diabetes UK, Harry Keen Intermediate Clinical Fellowship||Ad hoc reviewer for Diabetes UK, Harry Keen Intermediate Clinical Fellowship||2017|